International adaptation and use of NCCN Guidelines.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) describe a continuum of cancer care in the United States, from initial diagnosis through treatment and referral to hospice beyond treatment. However, in many other countries, there are no regional or national clinical practice guidelines. In 2008, the NCCN-MENA (Middle East and North Africa) project was launched to adapt the NCCN Guidelines to this part of the world. During their joint presentation at the NCCN 19th Annual Conference, Dr. Ali Bazarbachi and Dr. Andrew D. Zelenetz explored the modification process of NCCN Guidelines for MENA and shared examples of how it improved the care of patients with adult T-cell leukemia or lymphoma and younger patients with diffuse large B-cell lymphoma-regardless of where they live.
Presented by Ali Bazarbachi, MD, PhD, Professor of Medicine, Associate Dean for Basic Research, Director, Bone Marrow Transplantation Program, Faculty of Medicine, American University of Beirut, Beirut, Lebanon, and Andrew D. Zelenetz, MD, PhD, Professor of Medicine, Weill Medical College of Cornell University, and Vice Chair, Medical Informatics, Department of Medicine, and Attending Physician in the Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York City, New York.
Ali
A
Bazarbachi
Presented by Ali Bazarbachi, MD, PhD, Professor of Medicine, Associate Dean for Basic Research, Director, Bone Marrow Transplantation Program, Faculty of Medicine, American University of Beirut, Beirut, Lebanon, and Andrew D. Zelenetz, MD, PhD, Professor of Medicine, Weill Medical College of Cornell University, and Vice Chair, Medical Informatics, Department of Medicine, and Attending Physician in the Lymphoma Service, Memorial Sloan-Kettering Cancer Center, New York City, New York.
Andrew D
AD
Zelenetz
D000352:Africa, Northern; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D008877:Middle East; D017410:Practice Guidelines as Topic; D014481:United States